| [1] |
LIANG Xiumei, CHEN Weiyi, ZHOU Zihan, MA Liang, WU Yun, LU Xiangning, XIANG Bangde, YU Hongping, LYU Hanbin.
Analysis of survival characteristics in liver cancer inpatients: a 10-year follow-up cohort from a cancer hospital in Guangxi (2010—2020)
[J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 145-149.
|
| [2] |
LI Yongfeng, WAN Fengjie, WEN Sha, YANG Lichao, OU Meizhen, LIAO Zhouxiang, WU .
FAM50A gene knockdown suppresses malignant biological behaviors of colorectal cancer cells via the Caspase-3/PARP-mediated apoptotic signaling
[J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 180-187.
|
| [3] |
LI Liulin, LIU Hui , WANG Xiao, DENG Wanli.
Research advances in the pathogenesis of cancer-related sarcopenia
[J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 237-243.
|
| [4] |
DENG Yue, ZHAO Yue, ZHANG Shichuan.
Research progress of hypofractionated radiotherapy combined with immunotherapy in head and neck squamous cell carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 244-250.
|
| [5] |
LI Meng, LI Pingchuan, LIU Xiaoqiang, YANG Huawei.
Effects of MCM5 knockdown on proliferation,migration and apoptosis of breast cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 40-47.
|
| [6] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
| [7] |
YANG Jun, KANG Wei, ZHONG Wuning, ZHAO Xin.
Predictive value of radiomics model based on cone-beam breast CT images for pathological complete response of neoadjuvant therapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 103-108.
|
| [8] |
HUANG Shihuan, LAN Huiyu, NONG Xiaolian, LI Fanrong, ZHAO Fengjuan, YOU Xuemei.
Network analysis of concurrent symptoms and core symptom identification in patients with intermediate and advanced hepatocellular carcinoma after surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 729-735.
|
| [9] |
WANG Jinming, LI Yaojie, QIU Guogao, LIU Shaoping, LIU Jie, YOU Xuemei, MA Liang, ZHONG Jianhong.
ESMO 2024: new breakthroughs and future trends in hepatocellular carcinoma treatment
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 741-746.
|
| [10] |
LIU Zhiming, JIANG Jie.
Chemotherapy for advanced or recurrent endometrial cancer: progress,status and challenges
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 485-491.
|
| [11] |
WU Daying, JIANG Yao, LI Guiling .
Progress of chemotherapy for cervical cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 492-498.
|
| [12] |
LIU Linying, GUO Ciren, SUN Yang.
Progress of chemotherapy for vaginal malignant tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 499-503.
|
| [13] |
TAN Yue, LU Xin.
Progress of drug treatment for vulvar cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 510-515.
|
| [14] |
ZHOU Yufei, LI Kaiguo, YANG Xiaohui, CHEN Xuxia, CHEN Weiling, QU Song.
Effects of LGR4 on proliferation,apoptosis,invasion,migration and epithelial mesenchymal transformation of nasopharyngeal carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 525-532.
|
| [15] |
ZHANG Zhihong, CUI Wangfei, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Prediction model of high-risk population of upper gastrointestinal cancer and precancerous lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 549-555.
|
